Evidence map›Paper›PMID 16818909›Full record

ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2006

Clinical practice guidelines for the use of parathyroid hormone in the treatment of osteoporosis.

Anthony Hodsman, Scientific Advisory Council of Osteoporosis Canada, Alexandra Papaioannou, Clinical Guidelines Committee, Ann Cranney, Writing Group on the Systematic Review of Parathyroid Hormone for the Treatment of Osteoporosis

Abstract readComment
In one paragraph

Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Economic burden of osteoporosis in the world: A systematic review.Medical journal of the Islamic Republic of Iran · 2020
    Review
  6. Increased treatment persistence and its determinants in women with osteoporosis with prior fracture compared to those without fracture.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2016
    Article
  7. Review
  8. Osteoanabolics.Indian journal of endocrinology and metabolism · 2012
    Article
  9. Review
  10. Article
  11. Review
  12. Management of osteoporosis in men: an update and case example.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2007
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Anthony HodsmanDivision of Nephrology, University of Western Ontario and St. Joseph's Health Centre, London, Ont. anthony.hodsman@sjhc.london.on.ca
Scientific Advisory Council of Osteoporosis Canada
Alexandra Papaioannou
Clinical Guidelines Committee
Ann Cranney
Writing Group on the Systematic Review of Parathyroid Hormone for the Treatment of Osteoporosis

Funding

CIHR 73426-1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Practice Guidelines as TopicBone Density Conservation AgentsCanadaDiphosphonatesDrug InteractionsFemaleFractures, BoneHumansOsteoporosisParathyroid HormoneReview Literature as TopicTeriparatideBone Density Conservation AgentsDiphosphonatesParathyroid HormoneTeriparatide

Identifiers

PMID16818909
PMCPMC1482768

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.